Patentability of derivatives of known substance particularly drugs find a tough and bumpy road at Patent office in India since the introduction section […]

In the recent case of Novartis AG v Controller of Patents, the Delhi High Court allowed an appeal against the Controller’s refusal of an […]

India has been attracting global attention with its evolving IP ecosystem. This article captures some important patent provisions and recent patent-related updates from […]

As known by many in the Intellectual Property industry the WIPO was working on the tool named “WIPO sequence” since 2020. Its first […]

Story of exitance of polymorphism dates back to the year 1812 when Napoleon Bonaparte army wore highly decorated and shiny buttons on the […]

Looking beyond the novelty lines  Inventions already in the public domain are not patentable. Novelty or anticipation are determined with reference to the […]

The United States Trade Representative (USTR) has released its annual Special 301 Report, which assesses the state of intellectual property rights (IPR) protection […]

A recent judgement in the matter of Boehringer Ingelheim International Gmbh V. The Controller Of Patents & Anr. dated 12th July 2022 (corrected & released […]

India  In India, provisions dealing with plurality of distinct inventions have been discussed and interpretated in a catena of decisions issued by the […]

Patent rights are statutory right created under the terms and conditions of the national patent law. Nonetheless, if any patent protection is fraudulently […]